GenSight Biologics
SIGHT.PA
#9754
Rank
S$47.54 M
Marketcap
$0.36
Share price
2.25%
Change (1 day)
-48.71%
Change (1 year)

Earnings for GenSight Biologics (SIGHT.PA)

Earnings in 2023: -S$38.66 Million

According to GenSight Biologics's latest financial reports the company's current earnings are S$1.4 Million. In 2023 the company made an earning of -S$38.66 Million, an increase over its 2022 earnings that were of -S$39.51 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for GenSight Biologics from 2013 to 2023

Annual earnings

Year Earnings Change
2023-S$38.66 Million-2.16%
2022-S$39.51 Million-8.58%
2021-S$43.22 Million-22.54%
2020-S$55.79 Million21.01%
2019-S$46.11 Million-9.66%
2018-S$51.04 Million32.28%
2017-S$38.58 Million24.57%
2016-S$30.97 Million55.57%
2015-S$19.91 Million84%
2014-S$10.82 Million112.64%
2013-S$5.09 Million